Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Open Offer Excess

4 May 2020 07:00

RNS Number : 7408L
Surface Transforms PLC
04 May 2020
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

4 May 2020

 

Surface Transforms plc

("Surface Transforms" or the "Company")

 

Open Offer Excess

 

Surface Transforms plc (AIM:SCE) announced at 07:00 a.m. on 1 May 2020 that applications had been received in respect of the Open Offer of 9 April 2020 totaling 10,906,466 Open Offer Shares (equivalent to approximately £1.4 million) and representing a take-up of 473 per cent. Pursuant to the terms of the Open Offer, this had to be scaled back to 2,307,692 Open Offer Shares, raising gross proceeds of £0.3 million. The Company also announced that it was exploring various options to satisfy this additional excess demand.

 

The Board greatly appreciates this excess demand from its shareholders, and would welcome the opportunity to allot shares to those shareholders who applied for an excess of their entitlement in the Open Offer but whose applications were scaled back. Accordingly, the Board proposes that the Open Offer is increased such that a further 5,384,616 Open Offer Shares of the total applications for 10,906,466 Open Offer Shares be issued. This will increase the gross proceeds raised under the Open Offer to £1.0 million.

 

The Company will therefore be writing to this limited number of shareholders on 4 May 2020 and asking them to inform the Company if they do not wish to continue with their Open Offer application. Further details will be set out in that letter, but should Shareholders not wish to continue with their application, they should contact the Company at openoffer@surfacetransforms.com by 5:30 p.m. on 13 May 2020. If no reply is received the Company will assume that the shareholder has accepted the proposal and confirmed their wish to apply for new Ordinary Shares as aforementioned and will allot the shares by using the funds held by the Registrars, with the remaining funds being returned to the shareholder.

 

The issue of the additional 5,384,616 Open Offer Shares is conditional upon, amongst other things, approval by Shareholders at a General Meeting of the Company, expected to be held at Surface Transforms plc, Acornfield Rd, Knowsley Industrial Estate at 9.00 a.m. on Wednesday 20 May 2020. The Circular, together with a notice of the General Meeting, will be posted to Shareholders shortly. Shareholders will be asked to vote by proxy, and consistent with the government's social distancing measures will not be allowed to attend the General Meeting in person.

 

David Bundred, Chairman commented:

 

"As I noted in our announcement of 1 May, we are delighted with the strong support from all our shareholders who have participated in this placing and open offer. For a host of reasons, but not least a defensive plan should the Company's application for a CBILS loan not be successful, we have taken this opportunity to accept, subject to shareholder approval, a proportion of the excess applications received under the open offer. Assuming shareholders approve the increase in the open offer, the Company will have a considerably stronger balance sheet that would otherwise be the case, and can look to the future with optimism."

 

 

The person responsible for arranging the release of this announcement on behalf of the Company is Michael Cunningham, Finance Director.

 

For further information, please contact:

 

Surface Transforms plc.

 

Kevin Johnson, CEO +44 151 356 2141

David Bundred, Chairman

Michael Cunningham, Finance Director

 

Cantor Fitzgerald Europe (Nomad & Joint Broker) 

David Foreman, Michael Boot, Adam Dawes (Corporate Finance) +44 20 7894 7000

Caspar Shand Kydd, Maisie Atkinson (Sales)

 

finnCap Ltd (Joint Broker)

Richard Chambers (ECM) +44 20 7220 0500

Ed Frisby, Giles Rolls (Corporate Finance)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBXLLBBELFBBE
Date   Source Headline
13th Nov 20234:56 pmRNSProposed Placing, Subscription and Open Offer
3rd Nov 20237:05 amRNSTrading Update
16th Oct 20237:00 amRNS£100m New Business Award from OEM 10
28th Sep 20231:55 pmEQSHardman & Co Research on Surface Transforms (SCE): Interim results
27th Sep 20237:00 amRNSInterim results for six months ended 30 June 2023
31st Jul 20237:00 amRNSPre-close trading update and operations update
20th Jul 20237:00 amRNSDirector Dealing
5th Jul 20237:00 amRNSHolding(s) in Company
27th Jun 20235:02 pmRNSResult of Annual General Meeting
27th Jun 20237:00 amRNSAGM Statement
26th Jun 20234:55 pmRNSExercise of Options and Total Voting Rights
21st Jun 20237:00 amRNSAward of LSE Green Economy Mark
20th Jun 202311:38 amRNSPDMR Dealing
19th Jun 20237:00 amRNSAppointment of new Chief Finance Officer
2nd Jun 20237:00 amRNSExercise of Options and Total Voting Rights
31st May 202312:51 pmRNSPosting of Annual Report and Notice of AGM
30th May 20237:00 amRNSAppointment of new Chief Operating Officer
23rd May 20237:00 amRNSExercise of Options and Total Voting Rights
18th May 20231:30 pmEQSHardman & Co Q&A on Surface Transforms (SCE): Production ramp up secured in a potential £2bn a year market
9th May 20237:30 amEQSHardman & Co Research on Surface Transforms (SCE): A major quantum production ramp up now secured
5th May 20237:00 amRNSDirector Dealing
27th Apr 202312:35 pmEQSHardman & Co Video | Surface Transforms (SCE) Presentation and Q&A with the Board
24th Apr 20237:00 amRNSHolding(s) in Company
24th Apr 20237:00 amRNSDirector dealing and total voting rights
17th Apr 20237:00 amRNSPreliminary Results and Notice of AGM
6th Apr 202312:45 pmEQSHardman Talks Video Event | Surface Transforms Management Presentation and Q&A
3rd Apr 20237:00 amRNSProduction, Capacity and Trading Update
27th Jan 20232:34 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSTrading and operations update
20th Dec 20227:00 amRNSDirectorate Change
19th Dec 20227:00 amRNSPDMR Share Dealing & Total Voting Rights
15th Dec 202210:22 amEQSHardman & Co Research : Surface Transforms (SCE): Major OEM 10 order, OEM 8 delay resolved
24th Nov 20227:00 amRNSOEM 10 Contract Award and Trading Update
9th Nov 20224:42 pmRNSExercise of Options
27th Oct 202211:05 amRNSHolding(s) in Company
24th Oct 202211:15 amRNSHolding(s) in Company
20th Oct 20228:01 amRNSDirector Dealing
19th Oct 202212:23 pmRNSResult of General Meeting & Total Voting Rights
19th Oct 20227:00 amRNSResult of Open Offer
6th Oct 20222:20 pmEQSHardman & Co Research on Surface Transforms (SCE): The large growth is now self-financing
6th Oct 202212:05 pmEQSHardman & Co: Hardman Talks Video | Surface Transforms Surface Transforms presentation and Q&A with the Board
30th Sep 202211:02 amRNSInvestor Presentation
29th Sep 20221:25 pmEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms Management Presentation and Q&A
29th Sep 20228:33 amRNSResult of Placing, Open Offer Launch & GM Notice
28th Sep 20225:03 pmRNSProposed Placing, Subscription and Open Offer
12th Sep 202212:00 pmEQSHardman & Co Q&A on Surface Transforms (SCE): It's all in the detail
6th Sep 20227:15 amEQSHardman & Co Research on Surface Transforms (SCE): Further new order, upgrades, production ramp-up
5th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSContract award from OEM 9
19th Aug 20227:00 amRNSRetirement of non-executive director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.